Table 1.
patients’ demographics, preoperative and operative data analysis
| Characteristics | Value (%) |
|---|---|
| Gender | |
| Male | 8 (26.7) |
| Female | 22 (73.3) |
| Age (year), median (range) | 55 (25-86) |
| Smoking | |
| Yes | 2 (6.7) |
| No | 28 (93.3) |
| ASA | |
| I | 13 (43.3) |
| II | 15 (50) |
| III | 2 (6.7) |
| BMI (kg/m2), median (range) | 24.3 (19-35) |
| Primary site | |
| Rectal | 24 (77.4) |
| Sigmoid | 5 (16.2) |
| Uterine | 1 (3.2) |
| Cervix | 1 (3.2) |
| Tumor classification | |
| PA colorectal | 26 (83.9) |
| LR colorectal | 3 (9.7) |
| PA non-colorectal | 0 (0) |
| LR non-colorectal | 2 (6.4) |
| Type of operation | |
| PPE | 19 (61.3) |
| PPE with sacrectomy | 2 (6.4) |
| TPE | 10 (32.3) |
| Operative approach | |
| Open | 28 (90.3) |
| Laparoscopic | 3 (9.7) |
| Radicality | |
| R0 | 21 (67.7) |
| R1/R2 | 4/2 (19.3) |
| Not stated | 4 (13) |
| Operative time (hours), median (range) | 5.5 (4-11) |
| Stoma | |
| End colostomy | 20 (64.5%) |
| End ileostomy | 1 (3.2%) |
| Loop ileostomy | 4 (13%) |
| No | 6 (19.3%) |
| Neoadjuvant CRT | 19 (63.3) |
| Adjuvant chemotherapy | 22 (71) |
Values are presented as numbers (%) unless otherwise indicated; ASA: American Society of Anesthesiologists; BMI: body mass index; PA: primary advanced; LR: locally recurrent; PPE: posterior pelvic exenteration; TPE: total pelvic exenteration